
When will Cavenagh make THE Martin call?
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Chris Jack and Stevie Clifford are back with the latest episode of The Talking Point to discuss Russell Martin's future and Andrew Cavenagh's big decision.
Pressure continues to mount on Martin following the 1-0 defeat to Genk on Thursday night. Would another loss at Livingston be the final straw for the board?
Join the guys to discuss the anger and apathy amongst the support, what is at stake for Cavenagh and his hierarchy and that Premiership fixture on Sunday.
//
Have you downloaded our free app? Offering the best reader experience, the ability to watch our YouTube feed seamlessly and all the best Rangers news, analysis and opinion.
📱 Download on...
Apple: http://tinyurl.com/48djce83 or Android: http://tinyurl.com/ycz6zwnw
Welcome to the Rangers Review – the home of top-quality Rangers journalism. Your go-to source for daily news, match analysis, transfer updates, exclusive interviews, and all happenings at Ibrox Stadium and beyond.
We provide trustworthy, in-depth coverage of Rangers Football Club from a team of experienced journalists and analysts who live and breathe the Gers.
🎥 What We Offer:
☑️ Daily videos on Rangers news and match previews
☑️ Post-match analysis and fans' reactions
☑️ Exclusive interviews with players, coaches, and insiders
☑️ Tactical insights and transfer discussions
☑️ Live Q&As and content focused on fans
🗓️ New content uploaded daily — subscribe so you never miss out!
🔔 Subscribe here: https://www.youtube.com/@RangersReview
🌐 Visit our website: https://www.rangersreview.co.uk
📲 Follow us on Twitter/X: https://twitter.com/RangersReview55
📘 Like us on Facebook: https://www.facebook.com/RangersReview55
📸 Follow us on Instagram: https://www.instagram.com/rangersreview55
💬 Join the conversation in the comments and share your thoughts on the team, performances, transfers, and more.